Sex and Gender in Multidisciplinary PD Care 37 2 19. Willson T, Nelson SD, Newbold J, Nelson RE, LaFleur J. The clinical epidemiology of male osteoporosis: a review of the recent literature. Clin Epidemiol [Internet]. 2015 Jan 9;7:65–76. Available from: https://pubmed.ncbi.nlm.nih.gov/25657593 20. Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, et al. Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab [Internet]. 2012 Jun 1;97(6):1802–22. Available from: https://doi.org/10.1210/jc.2011-3045 21. Szewczyk-Krolikowski K, Tomlinson P, Nithi K, Wade-Martins R, Talbot K, Ben-Shlomo Y, et al. The influence of age and gender on motor and non-motor features of early Parkinson’s disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Park Relat Disord [Internet]. 2014;20(1):99–105. Available from: http://dx.doi.org/10.1016/j.parkreldis.2013.09.025 22. Sperens M, Georgiev D, Eriksson Domellöf M, Forsgren L, Hamberg K, Hariz G-M. Activities of daily living in Parkinson's disease: Time/gender perspective. Acta Neurol Scand. 2020 Feb;141(2):168–76. 23. Radder DLM, Sturkenboom IH, van Nimwegen M, Keus SH, Bloem BR, de Vries NM. Physical therapy and occupational therapy in Parkinson’s disease. Int J Neurosci. 2017 Oct;127(10):930–43. 24. Borkhoff CM, Hawker GA, Wright JG. Patient gender affects the referral and recommendation for total joint arthroplasty. Clin Orthop Relat Res [Internet]. 2011 Jul;469(7):1829–37. Available from: https://pubmed.ncbi.nlm.nih.gov/21448775 25. Hassin-Baer S, Molchadski I, Cohen OS, Nitzan Z, Efrati L, Tunkel O, et al. Gender effect on time to levodopa-induced dyskinesias. J Neurol. 2011 Nov;258(11):2048–53. 26. Shpiner DS, Di Luca DG, Cajigas I, Diaz JS, Margolesky J, Moore H, et al. Gender Disparities in Deep Brain Stimulation for Parkinson’s Disease. Neuromodulation. 2019 Jun;22(4):484–8. 27. Hariz G-M, Limousin P, Zrinzo L, Tripoliti E, Aviles-Olmos I, Jahanshahi M, et al. Gender differences in quality of life following subthalamic stimulation for Parkinson’s disease. Acta Neurol Scand. 2013 Oct;128(4):281–5. 28. Hamberg K, Hariz G-M. The decision-making process leading to deep brain stimulation in men and women with parkinson’s disease - an interview study. BMC Neurol. 2014 Apr;14:89. 29. Kon T, Ueno T, Haga R, Tomiyama M. The factors associated with impulse control behaviors in Parkinson’s disease: A 2-year longitudinal retrospective cohort study. Brain Behav [Internet]. 2018/06/29. 2018 Aug;8(8):e01036–e01036. Available from: https://pubmed.ncbi.nlm.nih. gov/29956879 30. Bhattacharjee S. Impulse control disorders in Parkinson’s disease: Review of pathophysiology, epidemiology, clinical features, management, and future challenges. Neurol India. 2018;66(4):967– 75. 31. Mathis MA de, Alvarenga P de, Funaro G, Torresan RC, Moraes I, Torres AR, et al. Gender differences in obsessive-compulsive disorder: a literature review. Rev Bras Psiquiatr. 2011 Dec;33(4):390–9. 32. Mathes BM, Morabito DM, Schmidt NB. Epidemiological and Clinical Gender Differences in OCD. Curr Psychiatry Rep. 2019;21(5):1–7. 33. Mele B, Holroyd-Leduc J, Smith EE, Pringsheim T, Ismail Z, Goodarzi Z. Detecting anxiety in individuals with Parkinson disease: A systematic review. Neurology. 2018 Jan;90(1):e39–47. 34. Schapira AH V, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017 Jul;18(7):435–50. 35. Marsh L. Depression and Parkinson’s disease: current knowledge. Curr Neurol Neurosci Rep. 2013 Dec;13(12):409. 36. Mayberg HS, Solomon DH. Depression in Parkinson’s disease: a biochemical and organic viewpoint. Adv Neurol. 1995;65:49–60.
RkJQdWJsaXNoZXIy MTk4NDMw